Investigate prion-like spreading of tau pathology through connected brain regions

PARTIALLY ADDRESSED

Priority: 0.90 Domain: neurodegeneration Hypotheses: 1

📊 Landscape Analysis

Landscape Summary: Investigate prion-like spreading of tau pathology through connected brain regions is a 0.9 priority gap in neurodegeneration. It has 1 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Investigate prion-like spreading of tau pathology through connected brain regions — INVOKE-2 (completed)

📈 Living Dashboards

Hypotheses

0.000

Top Score

0.000

Avg Score

Debates

0.86

Avg Quality

60%

Resolution

Mechanistic Families

Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

TREM2 Agonist Therapy to Redirect Microglial Exosome Content

Target: TREM2 Pathway: N/A

0.000

score

Cathepsin D Enhancement for Tau Degradation

Target: CTSD Pathway: N/A

0.000

score

GSK3β-Dependent Tau Phosphorylation Cycling Modulation

Target: GSK3B Pathway: N/A

0.000

score

Syndecan-Mediated Uptake Inhibition

Target: SDC4 Pathway: N/A

0.000

score

FYN-Mediated Extracellular Vesicle Release Inhibition

Target: FYN Pathway: N/A

0.000

score

APOE-Mediated Tau Clearance Enhancement

Target: APOE Pathway: N/A

0.000

score

BIN1-Targeted Extracellular Vesicle Trafficking Disruption

Target: BIN1 Pathway: N/A

0.000

score

CD63-Targeted Exosome Cargo Selectivity

Target: CD63 Pathway: N/A

0.000

score

Heparan Sulfate 3-O-Sulfation Modulators

Target: HS3ST1 Pathway: N/A

0.000

score

Lysosomal Membrane Stabilization to Prevent Tau Seeding

Target: LAMP1 Pathway: N/A

0.000

score

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed

📈 TREM2 Agonist Therapy to Redirect Microglial Exosome Content score=0.000 2026-04-28T22:03

📈 Cathepsin D Enhancement for Tau Degradation score=0.000 2026-04-28T22:03

📈 GSK3β-Dependent Tau Phosphorylation Cycling Modulation score=0.000 2026-04-28T22:03

📈 Syndecan-Mediated Uptake Inhibition score=0.000 2026-04-28T22:03

📈 FYN-Mediated Extracellular Vesicle Release Inhibition score=0.000 2026-04-28T22:03

🎭 Investigate prion-like spreading of tau pathology through co q=0.73 2026-04-22T14:56

✏ update on knowledge_gap by None 2026-04-21T14:21

🎭 Investigate prion-like spreading of tau pathology through co q=0.90 2026-04-12T08:56

🎭 Investigate prion-like spreading of tau pathology through co q=0.95 2026-04-03T17:10

🎭 Investigate prion-like spreading of tau pathology through co q=0.88 2026-04-02T07:29

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps